Is there a FUTURE for urodynamic testing in refractory overactive bladder syndrome?
- PMID: 40132617
- DOI: 10.1016/S0140-6736(25)00427-1
Is there a FUTURE for urodynamic testing in refractory overactive bladder syndrome?
Conflict of interest statement
DDA is a site primary investigator for the Cook Cellebrate Investigational New Drug trial and a consultant for La Grippe Research, has received honorarium for University of California, Los Angeles grand rounds, and was planning committee chair for the American Urogynecologic Society Pelvic Floor Disorder Conference 2024. SKR declares no competing interests.
Comment on
-
Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms (FUTURE) in the UK: a multicentre, superiority, parallel, open-label, randomised controlled trial.Lancet. 2025 Mar 29;405(10484):1057-1068. doi: 10.1016/S0140-6736(24)01886-5. Epub 2025 Mar 22. Lancet. 2025. PMID: 40132616 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
